Updated on 5/4/2020
Three IPOs and one SPAC are scheduled for the week ahead.
Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
CNS Pharmaceuticals, an early stage biotech developing therapies for brain cancer and other CNS tumors, raised $9 million by offering 2.1 million shares at $4, the low end of the range of $4 to $5, to command a fully diluted market value of $67 million. CNS...read more
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more
US IPO Week Ahead: GAN bets on itself in a 3 IPO week
Updated on 5/4/2020 Three IPOs and one SPAC are scheduled for the week ahead. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
US IPO Weekly Recap: Small Chinese and healthcare deals price down in an 8-IPO week
Eight small companies and four SPACs entered the public market this past week. Continuing a 4Q trend, all eight deals...read more
Micro-cap brain cancer biotech CNS Pharmaceuticals prices IPO at $4 low end
CNS Pharmaceuticals, an early stage biotech developing therapies for brain cancer and other CNS tumors, raised $9 million by offering 2.1 million shares at $4, the low end of the range of $4 to $5, to command a fully diluted market value of $67 million. CNS...read more
US IPO Week Ahead: The largest Canadian IPO ever leads a 9-IPO week
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more